• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病合并糖尿病患者血浆血栓调节蛋白-1 水平升高。

Higher plasma thrombospondin-1 levels in patients with coronary artery disease and diabetes mellitus.

机构信息

Departemnt of Cardiology, The Catholic University of Korea College of Medicine, Seoul, Korea.

出版信息

Korean Circ J. 2012 Feb;42(2):100-6. doi: 10.4070/kcj.2012.42.2.100. Epub 2012 Feb 27.

DOI:10.4070/kcj.2012.42.2.100
PMID:22396697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3291719/
Abstract

BACKGROUND AND OBJECTIVES

Thrombospondin-1 (TSP-1) is associated with atherosclerosis in animals with diabetes mellitus (DM). But, no study has investigated the role of TSP-1 in human atherosclerosis. This study investigated the relationship among plasma TSP-1 concentration, DM, and coronary artery disease (CAD).

SUBJECTS AND METHODS

The study involved 374 consecutive subjects with suspected CAD, who had undergone coronary angiography to evaluate effort angina. Patients were divided into four groups as follows: DM(-) and CAD(-), DM(-) and CAD(+), DM(+) and CAD(-), and DM (+) and CAD(+).

RESULTS

We found that plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) (n=103) than those in other patients (n=271) (p<0.01). A multivariate analysis showed that male gender {odds ratio (OR), 2.728; 95% confidence interval (CI), 1.035-7.187}, high density lipoprotein-cholesterol (OR, 0.925; 95% CI, 0.874-0.980), glycated hemoglobin (OR, 1.373; 95% CI, 1.037-1.817), and plasma TSP-1 (OR, 1.004; 95% CI, 1.000-1.008) levels were independently associated with the presence of CAD in patients with DM.

CONCLUSION

Plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) than those in other patients, and plasma TSP-1 levels were independently associated with the presence of CAD in patients with DM. These findings show a possible link between human plasma TSP-1 concentration and CAD in patients with DM.

摘要

背景与目的

血小板反应蛋白-1(TSP-1)与糖尿病(DM)动物的动脉粥样硬化有关。但是,尚无研究调查 TSP-1 在人类动脉粥样硬化中的作用。本研究调查了血浆 TSP-1 浓度、DM 和冠状动脉疾病(CAD)之间的关系。

受试者和方法

本研究涉及 374 例连续疑似 CAD 的患者,这些患者接受了冠状动脉造影以评估劳力性心绞痛。患者分为以下四组:DM(-)和 CAD(-)、DM(-)和 CAD(+)、DM(+)和 CAD(-)以及 DM(+)和 CAD(+)。

结果

我们发现,DM(+)和 CAD(+)患者(n=103)的血浆 TSP-1 水平高于其他患者(n=271)(p<0.01)。多变量分析显示,男性(优势比 [OR],2.728;95%置信区间 [CI],1.035-7.187)、高密度脂蛋白胆固醇(OR,0.925;95%CI,0.874-0.980)、糖化血红蛋白(OR,1.373;95%CI,1.037-1.817)和血浆 TSP-1(OR,1.004;95%CI,1.000-1.008)水平与 DM 患者 CAD 的存在独立相关。

结论

DM(+)和 CAD(+)患者的血浆 TSP-1 水平高于其他患者,并且血浆 TSP-1 水平与 DM 患者 CAD 的存在独立相关。这些发现表明人类血浆 TSP-1 浓度与 DM 患者 CAD 之间可能存在联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17b/3291719/d0070328d891/kcj-42-100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17b/3291719/d0070328d891/kcj-42-100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e17b/3291719/d0070328d891/kcj-42-100-g001.jpg

相似文献

1
Higher plasma thrombospondin-1 levels in patients with coronary artery disease and diabetes mellitus.冠心病合并糖尿病患者血浆血栓调节蛋白-1 水平升高。
Korean Circ J. 2012 Feb;42(2):100-6. doi: 10.4070/kcj.2012.42.2.100. Epub 2012 Feb 27.
2
Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.冠心病合并 2 型糖尿病患者低密度脂蛋白胆固醇/载脂蛋白 B 比值与富含甘油三酯脂蛋白的关系:一项横断面研究。
Cardiovasc Diabetol. 2017 Oct 2;16(1):123. doi: 10.1186/s12933-017-0606-7.
3
Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus.稳定型糖尿病患者冠状动脉 CT 血管造影的长期预后价值。
JACC Cardiovasc Imaging. 2016 Nov;9(11):1280-1288. doi: 10.1016/j.jcmg.2015.12.027. Epub 2016 Aug 24.
4
An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.印度南部人群中血栓反应蛋白 1 和 2 SNPs 与冠心病和心肌梗死的关联研究。
Thromb Res. 2011 Oct;128(4):e49-53. doi: 10.1016/j.thromres.2011.05.026. Epub 2011 Jul 16.
5
Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease.冠状动脉疾病患者血浆二肽基肽酶-4活性增加。
PLoS One. 2016 Sep 21;11(9):e0163027. doi: 10.1371/journal.pone.0163027. eCollection 2016.
6
Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.2型糖尿病合并冠状动脉疾病患者中血管内皮钙黏蛋白阳性内皮微粒水平升高。
J Am Coll Cardiol. 2005 May 17;45(10):1622-30. doi: 10.1016/j.jacc.2005.02.047.
7
Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.在经血管造影确诊为冠心病的患者中,血清脂蛋白(a)水平与2型糖尿病之间无关联。
Int J Cardiol. 2000 Jul 31;74(2-3):159-67. doi: 10.1016/s0167-5273(00)00304-1.
8
Association of plasma free fatty acids levels with the presence and severity of coronary and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus.血浆游离脂肪酸水平与 2 型糖尿病患者冠状动脉和颈动脉粥样硬化斑块的存在及严重程度的相关性研究。
BMC Endocr Disord. 2020 Oct 21;20(1):156. doi: 10.1186/s12902-020-00636-y.
9
Role of ankle-brachial pressure index as a predictor of coronary artery disease severity in patients with diabetes mellitus.踝臂指数在糖尿病患者冠状动脉疾病严重程度预测中的作用。
Can J Cardiol. 2009 Sep;25(9):e301-5. doi: 10.1016/s0828-282x(09)70140-0.
10
Diabetes Mellitus Is Associated With Increased Risk of Ischemic Stroke in Patients With and Without Coronary Artery Disease.糖尿病与伴有和不伴有冠状动脉疾病的缺血性卒中风险增加相关。
Stroke. 2019 Dec;50(12):3347-3354. doi: 10.1161/STROKEAHA.119.026099. Epub 2019 Nov 6.

引用本文的文献

1
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status.评估糖皮质激素状态的当前挑战和未来方向。
Endocr Rev. 2024 Nov 22;45(6):795-817. doi: 10.1210/endrev/bnae016.
2
Fibro-adipogenic progenitors in physiological adipogenesis and intermuscular adipose tissue remodeling.成纤维脂肪祖细胞在生理脂肪生成和肌间脂肪组织重塑中的作用。
Mol Aspects Med. 2024 Jun;97:101277. doi: 10.1016/j.mam.2024.101277. Epub 2024 May 23.
3
The molecular mechanism of thrombospondin family members in cardiovascular diseases.

本文引用的文献

1
Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability.N700S血小板反应蛋白-1多态性对蛋白质结构和稳定性的影响。
J Biol Chem. 2008 Jul 18;283(29):20069-76. doi: 10.1074/jbc.M800223200. Epub 2008 May 22.
2
A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II.一种转化生长因子-β激活的血小板反应蛋白-1拮抗剂可阻断糖尿病和血管紧张素II升高大鼠的心肌病。
Am J Pathol. 2007 Sep;171(3):777-89. doi: 10.2353/ajpath.2007.070056. Epub 2007 Jul 19.
3
Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease.
血小板反应蛋白家族成员在心血管疾病中的分子机制。
Front Cardiovasc Med. 2024 Mar 7;11:1337586. doi: 10.3389/fcvm.2024.1337586. eCollection 2024.
4
Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus.循环中血小板反应蛋白-1 水平升高与糖尿病血管并发症的关系。
J Diabetes Investig. 2024 Feb;15(2):197-207. doi: 10.1111/jdi.14095. Epub 2023 Oct 11.
5
Pathophysiology of Red Blood Cell Dysfunction in Diabetes and Its Complications.糖尿病及其并发症中红细胞功能障碍的病理生理学
Pathophysiology. 2023 Aug 2;30(3):327-345. doi: 10.3390/pathophysiology30030026.
6
Thrombospondin-1, CD47, and SIRPα display cell-specific molecular signatures in human islets and pancreata.血小板反应蛋白-1、CD47和信号调节蛋白α在人类胰岛和胰腺中呈现细胞特异性分子特征。
Am J Physiol Endocrinol Metab. 2023 Apr 1;324(4):E347-E357. doi: 10.1152/ajpendo.00221.2022. Epub 2023 Feb 15.
7
Proteomic analysis of descending thoracic aorta identifies unique and universal signatures of aneurysm and dissection.胸降主动脉的蛋白质组学分析确定了动脉瘤和夹层的独特及通用特征。
JVS Vasc Sci. 2022 Jan 22;3:85-181. doi: 10.1016/j.jvssci.2022.01.001. eCollection 2022.
8
Efficient Ex Vivo Screening of Agents Targeting Thrombospondin1-Induced Vascular Dysfunction Using a Digital Multiwire Myograph System.使用数字多线肌动描记系统对靶向血小板反应蛋白1诱导的血管功能障碍的药物进行高效体外筛选
Methods Protoc. 2021 Oct 14;4(4):74. doi: 10.3390/mps4040074.
9
Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers.心血管重塑中的糖基化与糖基化修饰:聚焦晚期糖基化终产物和O-连接糖基化作为与葡萄糖相关的致病因素和疾病标志物
J Clin Med. 2021 Oct 19;10(20):4792. doi: 10.3390/jcm10204792.
10
Novel Pharmaceutical Strategy for Selective Abrogation of TSP1-Induced Vascular Dysfunction by Decoy Recombinant CD47 Soluble Receptor in Prophylaxis and Treatment Models.诱饵重组CD47可溶性受体在预防和治疗模型中选择性消除TSP1诱导的血管功能障碍的新型药物策略。
Biomedicines. 2021 Jun 3;9(6):642. doi: 10.3390/biomedicines9060642.
稳定型冠状动脉疾病患者内皮功能与冠状动脉危险因素之间的关系
Circ J. 2007 May;71(5):698-702. doi: 10.1253/circj.71.698.
4
Increasing survival of ischemic tissue by targeting CD47.通过靶向CD47提高缺血组织的存活率。
Circ Res. 2007 Mar 16;100(5):712-20. doi: 10.1161/01.RES.0000259579.35787.4e. Epub 2007 Feb 9.
5
Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells.糖基化介导葡萄糖在血管平滑肌细胞中上调一种强效抗血管生成和促动脉粥样硬化蛋白——血小板反应蛋白-1。
J Biol Chem. 2007 Feb 23;282(8):5704-14. doi: 10.1074/jbc.M610965200. Epub 2006 Dec 18.
6
TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells.在人冠状动脉平滑肌细胞中,氟伐他汀可消除转化生长因子-β1通过p38丝裂原活化蛋白激酶途径诱导的血小板反应蛋白-1表达。
Vascul Pharmacol. 2006 Jun;44(6):469-75. doi: 10.1016/j.vph.2006.03.002. Epub 2006 Apr 19.
7
Regulation of tumor angiogenesis by thrombospondin-1.血小板反应蛋白-1对肿瘤血管生成的调节作用
Biochim Biophys Acta. 2006 Apr;1765(2):178-88. doi: 10.1016/j.bbcan.2005.11.002. Epub 2005 Dec 21.
8
Regulation of vascular genes by glucose.葡萄糖对血管基因的调控
Curr Pharm Des. 2005;11(18):2367-81. doi: 10.2174/1381612054367283.
9
Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.内源性血小板反应蛋白-1在预防愈合期心肌梗死扩展中的关键作用。
Circulation. 2005 Jun 7;111(22):2935-42. doi: 10.1161/CIRCULATIONAHA.104.510354. Epub 2005 May 31.
10
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.荟萃分析:糖尿病患者糖化血红蛋白与心血管疾病
Ann Intern Med. 2004 Sep 21;141(6):421-31. doi: 10.7326/0003-4819-141-6-200409210-00007.